Sign in
Taking people in United StatesNo phase

Brain stimulation that pauses during sleep for essential tremor

Tests deep brain stimulation that switches off automatically during sleep in essential tremor.

Key facts

Who runs it
University of Florida
Where
Gainesville, United StatesSee the site
Trial code
Registry title
Circadian Adaptive DBS in Essential Tremor
Status
Recruiting
People taking part
25 people, planned
Started
1 May 2025
Expected to end
Oct 2029
Type of study
Interventional, 2 groups
Treatments tested
  • Circadian Adaptive DBS
  • Conventional DBS
Record updated
30 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with essential tremor who already have a Medtronic Percept deep brain stimulation (DBS) device. It tests turning stimulation off automatically during sleep.

Age
21 to 89 years
Sex
All sexes
Disease stage
Essential tremor confirmed by a movement disorders specialist, using criteria set by the Movement Disorders Society.
Earlier treatment
People must already have DBS leads in the VIM area of the thalamus (one or both sides), connected to a Medtronic Percept DBS device. DBS must have improved tremor by 30% on the TRS or TETRAS at least 3 months after implantation. DBS must be set up in a monopolar setting that allows ongoing brain sensing (C+1- or C+2-).

Main reasons for not taking part

  • Not able to follow the study plan
  • Pregnancy
  • Current active thoughts of suicide (Yes to #2-5 on C-SSRS)
  • Personality or mood symptoms that study staff believe would get in the way of the study
  • Not able to give informed consent

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Diagnosis of Essential Tremor confirmed by a Movement Disorders specialist following established criteria recommended by the Movement Disorders Society
  • Patients implanted with unilateral or bilateral VIM DBS leads attached to the Medtronic Percept DBS device for the treatment of Essential Tremor
  • Patients with clinical benefit of DBS as defined by a 30% improvement on the TRS or TETRAS at least 3 months after DBS implantation
  • DBS programmed in a monopolar configuration allowing chronic brain sensing (C+1- or C+2- in ring mode or any direction)
  • Be between 21 and 89 years old
  • Ability to give informed consent for the study

Who cannot take part

  • Pregnancy: all women of childbearing potential will have a negative urine pregnancy test prior to undergoing the study
  • Inability to comply with the study protocol
  • Current active suicidal ideation (Yes to #2-5 on C-SSRS)
  • Any personality or mood symptoms that study personnel believe will interfere with study requirements

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 21 and 89 years old?

Where in United States

  • Norman Fixel Institute for Neurological DiseasesGainesville, United StatesContact: Julia C Gonzalez, BATaking people

About the trial

What the trial wants to find out

Deep brain stimulation (DBS) of the thalamus is an effective treatment for medically refractory essential tremor (ET). DBS involves delivering continuous stimulation to the brain through electrodes permanently implanted in the thalamus. Despite proven effectiveness, the long-term benefit of DBS can wane over time (habituation) and side effects, including paresthesia and dysarthria, often limit the amplitude of the stimulation, resulting in suboptimal control of tremor. In clinical practice, many groups advise patients to switch their devices off at night to avoid habituation and reduce side effects. However, manually turning off the device at night can result in uncontrolled tremor when the patient moves at night.

Read full original descriptionShow less

This study aims to develop an algorithm that automatically turns off stimulation when a patient is asleep, based on circadian brain signals. Turning off stimulation could potentially improve the therapy by limiting adverse effects, increasing efficacy, reducing the risk of habituation, and prolonging battery life. This study will evaluate the feasibility, safety, and tolerability of circadian adaptive DBS.

The 2 groups in the trial

  • Adaptive DBS, Then Conventional DBSTreatment being tested

    Participants will initially have their DBS programmed to automatically turn off during sleep for 2 weeks. Then, they will transition to continuous stimulation for another 2 weeks.

    Treatment: Circadian Adaptive DBS and Conventional DBS

  • Conventional DBS, then Adaptive DBSTreatment being tested

    Participants will initially have their DBS programmed with continuous stimulation for 2 weeks. Then, they will transition to having their DBS automatically turned off during sleep for another 2 weeks.

    Treatment: Circadian Adaptive DBS and Conventional DBS

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Circadian Adaptive Deep Brain Stimulation in Essential Tremor
Plain-language title
Brain stimulation that pauses during sleep for essential tremorGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT06635811, who can take part
Record updated
30 July 2026